Biochemical and Physiological Response to Stressogenic Stimuli
Measuring the Biochemical and Physiological Response to Controlled Stressogenic Stimuli
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Post-traumatic stress disorder (PTSD) is characterized by physiological changes, some of which are thought to be chronic, while others are observed in response to stressogenic stimuli. A psychiatric diagnosis of PTSD is currently based mainly on non-quantitative elements, such as interviews and subjective impressions. Discernable patterns of stress-related measures may constitute a physiological and biochemical phenotype characteristic of PTSD, which may serve as a biomarker and support diagnostic decisions, as well as personalized treatment plans. The current study is aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD. Physiological and biochemical data will be collected from participants with and without PTSD using wearable sensors and adhesive biosensor patches. The data will be collected in two conditions: in a neutral, quiet situation, and during and following exposure to controlled stressogenic stimuli.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedFirst Posted
Study publicly available on registry
September 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedSeptember 3, 2019
August 1, 2019
5 months
August 22, 2019
August 29, 2019
Conditions
Outcome Measures
Primary Outcomes (24)
Significant differences between groups - HRV
Significant differences in Heart Rate Variability - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - temperature
Significant differences in physiological changes - body temperature- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - SPO2
Significant differences in physiological changes - Saturation SPO2- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - blood pressure
Significant differences in physiological changes - continuous blood pressure- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - pulse pressure
Significant differences in physiological changes - pulse pressure - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups -respiratory rate
Significant differences in physiological changes - respiratory rate- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups -stroke volume
Significant differences in physiological changes - stroke volume- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups -cardiac output
Significant differences in physiological changes - cardiac output - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in physiological changes between groups - systemic vascular resistance
Significant differences in physiological changes - systemic vascular resistance- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in cortisol levels between groups
Significant differences in biochemical changes - cortisol - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - C-reactive protein
Significant differences in biochemical changes - C-reactive protein - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - Interleukin 6
Significant differences in biochemical changes - Interleukin 6 - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - N-terminal B-type natriuretic peptide
Significant differences in biochemical changes - N-terminal B-type natriuretic peptide - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - 8-oxo-7
Significant differences in biochemical changes - 8-oxo-7- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - 8-dihydro-2'-deoxyguanosine
Significant differences in biochemical changes - 8-dihydro-2'-deoxyguanosine - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - hexanone
Significant differences in biochemical changes - hexanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - acetic acid
Significant differences in biochemical changes - acetic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - heptane
Significant differences in biochemical changes - heptane - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - hexanal
Significant differences in biochemical changes -hexanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - 3-heptanone
Significant differences in biochemical changes - 3-heptanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - hexanoic acid
Significant differences in biochemical changes - hexanoic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - heptanal
Significant differences in biochemical changes -heptanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - nonanal
Significant differences in biochemical changes - nonanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Significant differences in biochemical changes between groups - glucose
Significant differences in biochemical changes - glucose - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
3 hours
Study Arms (2)
Pariticapnts with PTSD
EXPERIMENTALPariticapnts without PTSD (controls)
EXPERIMENTALInterventions
Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting
Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.
Eligibility Criteria
You may qualify if:
- PTSD diagnosis (excluding controls)
- Proper ability to give informed consent
You may not qualify if:
- Active oncological/cardiovascular condition
- Dialysis patients
- Active psychotic or suicidal symptoms
- Severe dissociative symptoms
- A traumatic brain injury (TBI) diagnosis
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nadav Goldentallead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 22, 2019
First Posted
September 3, 2019
Study Start
September 1, 2019
Primary Completion
February 1, 2020
Study Completion
June 1, 2020
Last Updated
September 3, 2019
Record last verified: 2019-08